Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Tremelimumab

Product Specifications

CAS Number

745013-59-6

Target

Others, Immunology/Inflammation related

Related Pathways

Immunology/Inflammation, Others

Purity

0.987

Bioactivity

Tremelimumab is a cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blocking antibody.Tremelimumab is often used in combination with Durvalumab for the treatment of solid cancers such as hepatocellular carcinoma and lung cancer.

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Lentiviral human ZNF441 sgRNA gene knockout kit - Lentiviral human ZNF441 sgRNA gene knockout kit (plasmid)
GTR15354619 1 Vial

Lentiviral human ZNF441 sgRNA gene knockout kit - Lentiviral human ZNF441 sgRNA gene knockout kit (plasmid)

Sign In for Pricing
View Details
Recombinant Human Nuclear Antigen Antibody
orb1151853-01 20 µg

Recombinant Human Nuclear Antigen Antibody

Sign In for Pricing
View Details
Recombinant Human Nuclear Antigen Antibody
orb1151853-02 100 µg

Recombinant Human Nuclear Antigen Antibody

Sign In for Pricing
View Details
Phospho-TSC1(Y304) Blocking Peptide
MBS9230850-01 0.5 mg

Phospho-TSC1(Y304) Blocking Peptide

Sign In for Pricing
View Details
Phospho-TSC1(Y304) Blocking Peptide
MBS9230850-02 5x 0.5 mg

Phospho-TSC1(Y304) Blocking Peptide

Sign In for Pricing
View Details
TBK1 Antibody
orb1174124-01 50 μL

TBK1 Antibody

Sign In for Pricing
View Details